Provided by Tiger Trade Technology Pte. Ltd.

Relay Therapeutics

20.57
+0.81004.10%
Post-market: 19.88-0.6900-3.35%19:30 EDT
Volume:2.74M
Turnover:56.35M
Market Cap:4.51B
PE:-13.14
High:20.77
Open:20.18
Low:20.05
Close:19.76
52wk High:21.27
52wk Low:3.44
Shares:219.14M
Float Shares:145.00M
Volume Ratio:1.08
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5651
EPS(LYR):-1.6113
ROE:-36.77%
ROA:-22.88%
PB:5.06
PE(LYR):-12.77

Loading ...

Oct 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2024

Major Issues Report

Form 8-K - Current report
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]